Cataract and Retinal Detachment in Patients with Severe Atopic Dermatitis Who Were Withdrawn from the Use of Topical Corticosteroid

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|26|10|658-665

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.26, Iss.10, 1999-10, pp. : 658-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pseudotumor Cerebri Associated with Cyclosporine Use in Severe Atopic Dermatitis

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 2, 2015-03 ,pp. : 237-239

John Wiley & Sons Inc

Access to resources Recommend Favorite

Foxp3+ regulatory T cells are expanded in severe atopic dermatitis patients

By  

ALLERGY, Vol. 70, Iss. 12, 2015-12 ,pp. : 1656-1660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1752-1753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre randomized, vehicle‐controlled clinical study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e169-e169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre, randomized, vehicle‐controlled clinical study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 424-432

John Wiley & Sons Inc

Access to resources Recommend Favorite